Experiments by nature: Lessons on type 1 diabetes

Research output: Contribution to journalArticle

Abstract

The etiology and pathogenesis of type 1 diabetes (T1D) - one of the most frequent chronic, life-debilitating diseases in humans - have long fascinated endocrinologists, pathologists and biologists alike. Currently conventional wisdom portrays T1D as a chronic T cell-mediated autoimmune disease that leads to the specific destruction of pancreatic insulin-producing β cells. The process of β cell destruction is accompanied (or preceded) by the production of autoantibodies (autoAb) to β cell antigens (i.e. insulin, GAD65, IA-2 and ZnT8). These autoAb have proved to be instrumental in identifying subjects at risk of developing the disease prior to overt hyperglycemia, and they help to distinguish T1D from T2D patients (who have no autoAb), but are not deemed to be pathogenic. This review will examine to which extent this well-established disease-dogmas are sustained by experiments by nature, which should not suffer from the common biases and errors of experiments by humans.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalTissue Antigens
Volume83
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Medical problems
Type 1 Diabetes Mellitus
Insulin
Experiments
Hyperglycemia
Autoantibodies
Autoimmune Diseases
T-cells
T-Lymphocytes
Antigens

Keywords

  • Autoantibodies
  • Autoimmunity
  • Dogmas
  • T cell-mediated responses
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Genetics

Cite this

Experiments by nature : Lessons on type 1 diabetes. / Battaglia, M.

In: Tissue Antigens, Vol. 83, No. 1, 01.2014, p. 1-9.

Research output: Contribution to journalArticle

@article{93b78de94bee45f99cad9a39d6ebff3f,
title = "Experiments by nature: Lessons on type 1 diabetes",
abstract = "The etiology and pathogenesis of type 1 diabetes (T1D) - one of the most frequent chronic, life-debilitating diseases in humans - have long fascinated endocrinologists, pathologists and biologists alike. Currently conventional wisdom portrays T1D as a chronic T cell-mediated autoimmune disease that leads to the specific destruction of pancreatic insulin-producing β cells. The process of β cell destruction is accompanied (or preceded) by the production of autoantibodies (autoAb) to β cell antigens (i.e. insulin, GAD65, IA-2 and ZnT8). These autoAb have proved to be instrumental in identifying subjects at risk of developing the disease prior to overt hyperglycemia, and they help to distinguish T1D from T2D patients (who have no autoAb), but are not deemed to be pathogenic. This review will examine to which extent this well-established disease-dogmas are sustained by experiments by nature, which should not suffer from the common biases and errors of experiments by humans.",
keywords = "Autoantibodies, Autoimmunity, Dogmas, T cell-mediated responses, Type 1 diabetes",
author = "M. Battaglia",
year = "2014",
month = "1",
doi = "10.1111/tan.12280",
language = "English",
volume = "83",
pages = "1--9",
journal = "Tissue Antigens",
issn = "0001-2815",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Experiments by nature

T2 - Lessons on type 1 diabetes

AU - Battaglia, M.

PY - 2014/1

Y1 - 2014/1

N2 - The etiology and pathogenesis of type 1 diabetes (T1D) - one of the most frequent chronic, life-debilitating diseases in humans - have long fascinated endocrinologists, pathologists and biologists alike. Currently conventional wisdom portrays T1D as a chronic T cell-mediated autoimmune disease that leads to the specific destruction of pancreatic insulin-producing β cells. The process of β cell destruction is accompanied (or preceded) by the production of autoantibodies (autoAb) to β cell antigens (i.e. insulin, GAD65, IA-2 and ZnT8). These autoAb have proved to be instrumental in identifying subjects at risk of developing the disease prior to overt hyperglycemia, and they help to distinguish T1D from T2D patients (who have no autoAb), but are not deemed to be pathogenic. This review will examine to which extent this well-established disease-dogmas are sustained by experiments by nature, which should not suffer from the common biases and errors of experiments by humans.

AB - The etiology and pathogenesis of type 1 diabetes (T1D) - one of the most frequent chronic, life-debilitating diseases in humans - have long fascinated endocrinologists, pathologists and biologists alike. Currently conventional wisdom portrays T1D as a chronic T cell-mediated autoimmune disease that leads to the specific destruction of pancreatic insulin-producing β cells. The process of β cell destruction is accompanied (or preceded) by the production of autoantibodies (autoAb) to β cell antigens (i.e. insulin, GAD65, IA-2 and ZnT8). These autoAb have proved to be instrumental in identifying subjects at risk of developing the disease prior to overt hyperglycemia, and they help to distinguish T1D from T2D patients (who have no autoAb), but are not deemed to be pathogenic. This review will examine to which extent this well-established disease-dogmas are sustained by experiments by nature, which should not suffer from the common biases and errors of experiments by humans.

KW - Autoantibodies

KW - Autoimmunity

KW - Dogmas

KW - T cell-mediated responses

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84890653791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890653791&partnerID=8YFLogxK

U2 - 10.1111/tan.12280

DO - 10.1111/tan.12280

M3 - Article

C2 - 24355002

AN - SCOPUS:84890653791

VL - 83

SP - 1

EP - 9

JO - Tissue Antigens

JF - Tissue Antigens

SN - 0001-2815

IS - 1

ER -